Literature DB >> 4209052

In vitro activity of cephalosporins against Mycobacterium tuberculosis H37Rv: structure-activity relationships.

M Misiek, A J Moses, T A Pursiano, F Leitner, K E Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4209052     DOI： 10.7164/antibiotics.26.737

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN： 0021-8820            Impact factor:   2.649


× No keyword cloud information.
  4 in total

1.  Recombinant expression and characterization of the major beta-lactamase of Mycobacterium tuberculosis.

Authors:  R K Voladri; D L Lakey; S H Hennigan; B E Menzies; K M Edwards; D S Kernodle
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

2.  Determination of in vitro susceptibility of Mycobacterium tuberculosis to cephalosporins by radiometric and conventional methods.

Authors:  L B Heifets; M D Iseman; J L Cook; P J Lindholm-Levy; I Drupa
Journal:  Antimicrob Agents Chemother       Date:  1985-01       Impact factor: 5.191

Review 3.  Have we realized the full potential of β-lactams for treating drug-resistant TB?

Authors:  Elizabeth Story-Roller; Gyanu Lamichhane
Journal:  IUBMB Life       Date:  2018-06-22       Impact factor: 3.885

4.  Repurposing clinically approved cephalosporins for tuberculosis therapy.

Authors:  Santiago Ramón-García; Rubén González Del Río; Angel Santos Villarejo; Gaye D Sweet; Fraser Cunningham; David Barros; Lluís Ballell; Alfonso Mendoza-Losana; Santiago Ferrer-Bazaga; Charles J Thompson
Journal:  Sci Rep       Date:  2016-09-28       Impact factor: 4.379
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.